An FDA inspection tests a small number of things repeatedly. Does the written food safety plan describe the process the facility actually runs? Can records be produced promptly and followed from receiving to shipment? Does the person responsible understand what the plan requires of them? Where those hold, an inspection is a routine professional event.
Where they do not, the inspection lengthens, because time gets spent reconstructing rather than reviewing — and reconstruction under observation is where avoidable observations are generated.
What preparation covers
Preparation is not a single walkthrough the week before. It is a set of specific readiness conditions, most of which take longer to establish than people expect.
- Reconciliation of the food safety plan against the current process flow, equipment, product mix and suppliers
- A records review sweep: monitoring, corrective action, verification and validation records complete, signed and reviewed
- Document staging so requests are answered from a known location rather than a search
- A mock inspection covering opening interview, floor walk, document requests and closing discussion
- Preparation for the named PCQI on what the role requires and how the plan will be questioned
- Front-desk and escort protocol: who greets, who accompanies, who is authorised to speak to what
- A clear internal rule on answering: confirm before answering, never speculate, never guess at a number
- Environmental monitoring and sanitation records, including how positive results were handled
The floor issues that draw attention
Investigators observe conditions, not intentions. Standing water, condensate over exposed product, damaged food-contact surfaces, gaps in pest exclusion, and equipment that cannot be effectively cleaned are visible and difficult to explain away.
Environmental monitoring is a specific area worth attention. A program in a wet, complex, ready-to-eat environment that has never detected an indicator organism usually indicates weak site selection rather than a sterile plant — and an investigator may read it the same way. Equally important is having a documented response plan for a positive result before one occurs.
If observations are issued
A Form FDA 483 records inspectional observations. It is not a final determination that a violation exists, but the response shapes what follows. Map each observation to its regulatory basis first; several observations frequently trace to a single root cause, and addressing that systemically is stronger than writing unrelated corrective actions.
A credible response addresses each observation individually with root cause analysis that goes past operator error, dated corrective actions, preventive actions covering other areas exposed to the same cause, verification of effectiveness, and objective evidence attached.
Where enforcement exposure exists, qualified counsel should review the submission. We build the technical content; we are not a law firm and do not advise on legal strategy. And whatever is committed to with a future date must be tracked — an unfulfilled commitment discovered at the next inspection is worse than the original observation.
SURU Compliance is an independent regulatory consulting practice. We are not the FDA or any other government agency, not a certification body or accredited certifying entity, and not a law firm. We do not provide FDA approval, guaranteed inspection or audit outcomes, or legal advice, and we refer legal matters to qualified counsel. Regulatory applicability depends on your specific products, processes, size and jurisdiction.